CBSE Class 12 Biology Pre Board Sample Paper 2025-2026: The CBSE Class 12 Biology Pre-Board Exam 2026 will be conducted on 27 March 2026 (Friday). As the exam date approaches, students are preparing ...
The important questions for CBSE Class 12 are curated carefully based on past exam patterns, high-weightage chapters, and the latest sample papers. These questions help students practise concepts that ...
GameSpot may get a commission from retail offers. Diablo 4 players don't have to wait until next year's Lord of Hatred expansion to play one of its new classes, as the fan-favorite Paladin is playable ...
Drew Swanson is a Features Article Editor from the Pacific Northwest of the United States. He is a lifelong gamer with a passion for a variety of genres. A connoisseur of everything from JRPGs and ...
Drew Swanson is a Features Article Editor from the Pacific Northwest of the United States. He is a lifelong gamer with a passion for a variety of genres. A connoisseur of everything from JRPGs and ...
Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...
RPG Warhammer 40,000: Dark Heresy shows off equal helpings of sleuthing and smashing in its new trailer, as its first playable alpha test goes live Baldur's Gate Baldur's Gate 3 started on top and ...
The new cast of SUR-vers on Vanderpump Rules Season 12 may just now be clocking in for the official shift change, but that doesn't mean they never crossed paths with the OGs who came before them. In ...
Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; ...
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of ...
The mid-nineteenth century saw the development of a radical new direction in chemistry: instead of simply analyzing existing molecules, chemists began to synthesize them—including molecules that did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback